ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

MNOV Medicinova Inc

1,38
0,09 (6,98%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Medicinova Inc MNOV NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,09 6,98% 1,38 00:36:14
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,29 1,29 1,38 1,38 1,29
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.4.202401:00GLOBEMediciNova Announces Abstract Regarding Results of a..
27.3.202400:00GLOBEMediciNova Receives a Notice of Allowance for a New Patent..
21.3.202400:00GLOBEMediciNova Announces Two Abstracts regarding MN-001..
12.3.202411:30GLOBEMediciNova Announces New Data and Results of MN-166..
15.2.202422:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
19.1.202422:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
19.1.202422:25EDGAR2Form S-8 POS - Securities to be offered to employees in..
19.1.202422:23EDGAR2Form S-8 POS - Securities to be offered to employees in..
19.1.202422:21EDGAR2Form S-8 POS - Securities to be offered to employees in..
17.1.202412:00GLOBEMediciNova Receives a Notice of Grant for a New Patent..
11.1.202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.1.202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.1.202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.12.202300:00GLOBEMediciNova Announces Abstract Regarding MN-166 (ibudilast)..
07.12.202300:00GLOBEMediciNova Receives a Notice of Decision to Grant for a New..
20.11.202313:42IHMARKETNEWSStocks Set to Open Higher as Investors Await FOMC Minutes..
20.11.202300:00GLOBEMediciNova Announces New Data and Results of a Phase 2..
09.11.202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27.10.202307:00GLOBEMediciNova’s Collaborator Initiates Clinical Development of..
11.10.202301:00GLOBEMediciNova Receives a Notice of Allowance for a New Patent..
05.10.202301:00GLOBEMediciNova Receives Gene Therapy Milestone Payment
28.9.202301:00GLOBEMediciNova Announces Results of Studies under BARDA Contract..
18.8.202301:00GLOBEMediciNova Announces Abstract Regarding MN-166 (ibudilast)..
17.8.202301:00GLOBEMediciNova Receives a Notice of Intention to Grant for a New..
16.8.202301:00GLOBEMediciNova Receives a New Patent Covering MN-001 for the..
15.8.202301:00GLOBEMediciNova Receives a Notice of Intention to Grant for a New..
09.8.202322:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202322:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.8.202322:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
07.8.202322:05EDGAR2Form 8-K - Current report
29.6.202312:00GLOBEMediciNova Announces Presentation of Results from the Phase..
15.5.202301:00GLOBEMediciNova Receives a Notice of Intention to Grant for a New..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock